Nemec Sarah's Form 4 filing
Bolt Biotherapeutics, Inc. (BOLT) · filed May 5, 2025
- Accession no.
- 0000950170-25-063846
- Filed
- May 5, 2025
- Trade date
- Jun 6, 2024-May 1, 2025
- Filing delay
- 333 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $2.85K. It was filed 333 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nemec SarahCIK 0002023538 | Officer (Senior VP, Finance and PAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Common Stock | PPurchaseAcquired | +2,500 | $0.50 | +$1,250 | 16,633 | Direct | |
| Jun 6, 2024 | Common Stock | PPurchaseAcquired | +2,500 | $0.64 | +$1,600 | 13,863 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | Common Stock | AGrant or awardAcquired | +226,000 | $0.00 | $0 | 226,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.